Official Journal of Japan Society of Ningen Dock
Online ISSN : 2186-5027
Print ISSN : 1880-1021
ISSN-L : 1880-1021
Original Articles
Comparison of 2nd Fiscal Year's Medical Checkup Results between Examinees who Received Specific Health Guidance for Metabolic Syndrome and Those who Received No Guidance (Including Those on Medication)
Nobuhiko YoshidaKumiko NakamuraHiromi KawaiKazuhiko HoshinoShinichiro Kume
Author information
JOURNAL FREE ACCESS

2012 Volume 27 Issue 4 Pages 707-714

Details
Abstract
Objective: Examinees not on medication (ENoM) may receive specific health guidance (SHG)if they have positive criteria (PoC) comprising obesity and positive additional risks (PAR) including hypertension, hyperglycemia, dyslipidemia and smoking, but examinees who are on medication (EOnM) for hypertension, diabetes, or dyslipidemia may not, even if they have PoC. This is because they are under the guidance of clinicians. We analyzed examination data for ENoM and EOnM, after a year to see the effects of guidance.
Methods: Our subjects were 3,002 men between 40 and 64 years old belonging to a certain health insurance society who underwent specific health examinations for 2 consecutive years. The diagnosis was conducted for EOnM subjects assuming that they were not on medication and accordingly such subjects with PoC were assumed to be those who should receive SHG. Obesity was taken to represent a state in which waist circumference or body mass index exceeds a reference level.
Results: Disappearance rates for obesity, PAR and PoC indicated by the 2nd year’s data for EOnM with PoC were 8.6%, 7.1% and 14.8%, respectively. These rates were significantly lower than those for ENoM who received SHG (23.3%,15.3% and 34.1%, respectively), but there was no significant difference between them and ENoM who did not receive SHG for personal reasons (8.5%,8.5% and 16.4%respectively ). At the 2nd year, 19.3% of criteria-negative EOnM became criteria-positive, significantly higher than the 9.6% rate for ENoM. For obese examinees, there were high rates of becoming criteria-positive, of 62.2% and 42.2% for EOnM and ENoM, respectively.
Conclusion: SHG is effective in the resolution of obesity and additional risks. It might be better to include EOnM with PoC among recipients of SHG and perhaps obese examinees with no additional risks should receive other special guidance, whether they are on medication or not.
Content from these authors
© 2012 Japan Society of Ningen Dock
Previous article Next article
feedback
Top